As research expands , we may see cagrilintide incorporated into combination protocols not just with semaglutide , but potentially tirzepatide, retatrutide , and other emerging incretin-mimetics
The data reveals patterns so consistent they appear in roughly 85% of patients who complete treatment
As in past years, this years survey included questions on the cost of health insurance, offer rates, coverage, eligibility, enrollment patterns, premiums, employee cost sharing, prescription drug benefits, retiree health benefits, wellness benefits, and employer opinions
The big driver is under-fueling
Researchers focused on members who had a GLP-1 drug claim between Jan
A positive recommendation could restore broader compounding access, while a negative recommendation could effectively reinstate restrictions